secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2025-06-03T23:59:59+00:00
Accession:  0001641172-25-013491
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera supplements proxy statement reclassifying two proposals as routine matters for broker voting
--------------------------------------------------------------------------------

- NYSE determined Proposal Nos. 2 and 3 are routine; brokers may vote without instructions, reversing earlier disclosure.
- Proposal No. 2 increases authorized common shares from 35M to 70M; Proposal No. 3 is an adjournment measure.
- Proxies already received remain valid unless revoked; annual meeting still set for June 12, 2025.
- Only Proposal No. 4 (ratification of auditor) was previously listed as routine in the original proxy statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000164117225013491/0001641172-25-013491-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000164117225013491/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-013491

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer